Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
about
Epilepsy related to developmental tumors and malformations of cortical developmentInflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expressionmTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.The genomic landscape of tuberous sclerosis complexmTOR signaling in epilepsy: insights from malformations of cortical developmentTuberous sclerosis complex neuropathology requires glutamate-cysteine ligaseNovel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.Differential expression of major histocompatibility complex class I in developmental glioneuronal lesionsDownregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC).Tsc1 expression by dendritic cells is required to preserve T-cell homeostasis and response.Evolving neurobiology of tuberous sclerosis complex.mTOR inhibitors as a new therapeutic option for epilepsy.mTOR signaling and its roles in normal and abnormal brain development.Immunocytochemical markers of neuronal maturation in human diagnostic neuropathology.Immunity and Inflammation in Epilepsy.Prospective clinical trials to investigate clinical and molecular biomarkers.Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macroCoding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.No evidence for human papillomavirus infection in focal cortical dysplasia IIb.mTOR-Dependent Cell Proliferation in the Brain.Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex.Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming.Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures.Type II focal cortical dysplasia: Ex vivo 7T magnetic resonance imaging abnormalities and histopathological comparisons.Malformations of cortical development and epilepsy
P2860
Q26829946-77381A0B-E105-41F5-8301-9C8E9337D61DQ27308042-0B1F1B6F-FA73-48D4-B050-1556563B4455Q27320332-BC22D505-0DBD-47D5-AAAD-D1B6028BF666Q30539812-0A11A1BA-0F7A-4DCE-8F1E-23C74E66A663Q30804418-958D8358-29C0-4F7A-87FE-EF08D3192573Q33275854-100E6EDA-2031-4098-A606-902059E355A7Q33826893-116C024C-D45B-4B6D-830D-F6593AB14913Q35245211-108628C4-C284-416A-A0C8-E532793FE909Q35899265-C5D9A8F0-7006-4624-822E-78D6BE9FBD0FQ36050518-F5CE79A9-1D2B-41B0-95FF-FF19FCDF16ACQ36591782-391CB7D0-CB03-4312-8EBE-982996CB3810Q36815367-56295759-BD11-4AA1-A49F-8B4C136432EBQ37150425-9DF10CB9-EBEB-47BE-8D08-B025FA386A01Q37744972-B57493A5-3FF2-4BAE-8E22-90C5D6166E82Q38079547-A0F09961-6D62-47AF-81F3-8511D9799632Q38112211-B02BC884-FAE6-4018-A124-0EB2753705F3Q38209310-42BB4CB4-FD59-4E6A-8A6C-5DDAA8E0FB58Q38250190-0A0FFCA4-857A-4519-AD45-48435379EAB4Q38673807-CCE26D01-C15D-4250-BCEE-515BB4147C6DQ38694561-759D3A7A-3AF7-4765-BD4F-B24C03EB5D4CQ39173616-2A27C2AF-34C0-4FD3-AC50-C538ABFC3D82Q40083141-CC9E8ED6-E102-4C2C-B4A6-9EE005B8A9E4Q41612629-26717087-A6F1-4509-9A03-D84742822F20Q47231432-1B7C0C55-7D24-4A82-8B9B-0990375A825FQ48593173-E8BE7FFA-FEE6-4E96-8F34-2EDD452BF1F8Q49650210-B6B0DC43-8D49-4816-A3E1-C414BE7BEF41Q50305423-D3D31E17-4E4D-4771-9042-7F101F54B216Q52148247-08B56455-7C57-4FA1-A35D-8D594722D932Q56770849-A7E1191A-5973-4909-ADDA-86D5B36B7AE0
P2860
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@ast
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@en
type
label
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@ast
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@en
prefLabel
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@ast
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@en
P2093
P2860
P1433
P1476
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation
@en
P2093
Ans M W van den Ouweland
Avanita S Prabowo
Harvey B Sarnat
Jasper J Anink
Laura Flores-Sarnat
Mark Nellist
Martin Lammens
Peter B Crino
P2860
P356
10.1111/J.1750-3639.2012.00616.X
P577
2012-08-30T00:00:00Z